Mortality due to blaKPC Klebsiella pneumoniae bacteraemia-authors' response

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 6, 2016, Pages 1744-1745

  Wiener Well, Yonit ^a   Raveh Brawer, David ^a   Fraenkel Wandel, Yedidah ^a   Yinnon, Amos M ^a   Assous, Marc V ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; FOSFOMYCIN; GENTAMICIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE BACTERAEMIA; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; BACTEREMIA; KLEBSIELLA INFECTION;

BACTEREMIA; BETA-LACTAMASES; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE;

EID: 84973307908     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw059     Document Type: Letter

References (5)

1. Giacobbe DR, Tumbarello M, Del Bono Vet al. Comment on: Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother 2016; 71: 1743-4.
2. Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Yet al. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother 2016; 71: 1083-7.
3. Esterly JS, Wagner J, McLaughlin MM et al. Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification. Antimicrob Agents Chemother 2012; 56: 4885-90.
4. Benenson S, Yinnon AM, Schlesinger Y et al. Optimization of empirical antibiotic selection for suspected Gram-negative bacteraemia in the emergency department. Int J Antimicrob Agents 2005; 25: 398-403.
5. Leclercq R, Cantón R, Brown DFJ et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013; 19: 141-60.